首頁
Stemedica Cell Technologies, Inc.

7月 2026Stemedica Cell Technolog...的市場佔有率分析

科學與教育 > 生物學

域名stemedica.com

成立年份2005

僱員51 - 200

年度營收$15M - $25M

Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies, Inc.（包含公司地區）

stemedica.com

查看更多網站流量與參與度資訊

Stemedica Cell Technologies, Inc.截至 7月 2026 的總收入為 15M - 25M

Stemedica Cell Technologies, Inc. 熱門網域產生的總收入

Stemedica Cell Technologies, Inc. 熱門網域 3 年內的總收入

Stemedica Cell Technologies, Inc. 熱門網域的總收入

stemedica.com15M - 25M

透過銷售情報查看更多內容

Stemedica Cell Technologies, Inc.的熱門網域總造訪量

了解Stemedica Cell Technologies, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

stemedica.com1.9K

透過銷售情報查看更多內容

Stemedica Cell Technologies, Inc.的熱門網域平均造訪時長

分析Stemedica Cell Technologies, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

stemedica.com00:00:34

透過銷售情報查看更多內容

Stemedica Cell Technologies, Inc.的熱門網域平均頁面瀏覽量

了解Stemedica Cell Technologies, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

stemedica.com2.38

透過銷售情報查看更多內容

Stemedica Cell Technologies, Inc.按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Stemedica Cell Technologies, Inc.

这些是Stemedica Cell Technologies, Inc.顶级域名使用的行业网站技术

轉換與分析 (6)

Google Analytics

付費廣告 (5)

Google Adsense

內容管理系統 (2)

WordPress

市場行銷 (2)

Google Marketing Platform

更多技術

6

檢視所有

新聞與訊號來自Stemedica Cell Technologies, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Stemedica Cell Technologies, Inc. hired Michael K. Steinhauser as Chief Executive Officer and Interim Chairman of the Board on May 31st '23.The Board of Directors of Stemedica Cell Technologies, a best-in-class manufacturer of ischemic tolerant stem cells, announced today that it has appointed Michael K. Steinhauser as Chief Executive Officer and Interim Chairman of the Board.

新聞Stemedica Cell Technologies, Inc. launches IV allogenic mesenchymal stem cell treatment for patients with chronic ischemic stroke.Stemedica Cell Technologies announced the launch of a phase 2b/3 clinical trial of its IV allogenic mesenchymal stem cell treatment for patients with chronic ischemic stroke.

新聞Stemedica Cell Technologies, Inc. hired Darius Anderson as Board of Directors on Mar 31st '22.Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego -based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has appointed Darius Anderson, a veteran business executive and one of the state of California's most respected entrepreneurs and political strategists, to its Board of Directors.